The cleaning processes used in pharmaceutical operations have achieved an increasing emphasis in the past decade both by the regulatory agencies and industry itself. At this time it is generally regarded as just as critical to have effective cleaning processes as to have consistent, validated manufacturing processes. Several developments have caused this emphasis on the cleaning process. First, the new generation of products (as well as those in the current "pipeline") tends to be more potent (e.g., many are potent in mg and sub-mg doses). Second, a series of tragic contaminations occurred over the last several years that led to serious personal injury. In addition, we know that many individuals are sensitive to various drugs and that these sensitivities, often described as allergenicities, can be very serious. The basic reason for having good, effective, consistent cleaning procedures is to prevent the contamination of products made subsequently in the same equipment. The goal is to provide pharmaceutical products of the highest quality to our patients. This is the basic regulatory requirement as well as the goal of all of those suppliers of products and services.
Introduction
The cleaning processes used in pharmaceutical operations have achieved an increasing emphasis in the past decade both by the regulatory agencies and industry itself. At this time it is generally regarded as just as critical to have effective cleaning processes as to have consistent, validated manufacturing processes. Several developments have caused this emphasis on the cleaning process. First, the new generation of products (as well as those in the current "pipeline") tends to be more potent (e.g., many are potent in mg and sub-mg doses). Second, a series of tragic contaminations occurred over the last several years that led to serious personal injury. In addition, we know that many individuals are sensitive to various drugs and that these sensitivities, often described as allergenicities, can be very serious.The basic reason for having good, effective, consistent cleaning procedures is to prevent the contamination of products made subsequently in the same equipment. The goal is to provide pharmaceutical products of the highest quality to our patients. This is the basic regulatory requirement as well as the goal of all of those suppliers of products and services.
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Materials and Methods
Materials
Metformin Hydrochloride (MFH) was obtained as gift sample from Harman Finochem Pvt.
Ltd., Aurangabad, Maharashtra, India. All other chemicals used were of analytical grade.
Methods
20 tablets of metformin (Glycomet 250mg) was weighed and powdered and powder equivalent to 0.1 gm of metformin was weighed and shaked with 70ml of water for 15 min, it was then diluted to 100ml with water and finally filtered.10ml of the filtrate was diluted to100ml with water. Further 10ml of it was diluted to100ml with water and the absorbance of the resulting solution was measured at the max at about 232nm. The content of metformin HCl was calculated taking 798 as a value of a 1%/ 1cm at 232nm.
Analytical Method Validation Calibration
Curve (Metformin Hydrochloride) The calibration curve of Metformin was taken using UV Spectrophotometer at 232 nm (Shimadzu UV-1800).
Linearity
The drug shows linear curve up to 0.1-25µg/mL.
Forced degradation Studies NaOH degradation study
The degradation studies in 0.1 N NaOH was carried out in accordance to section 6.3.3
Hydrogen peroxide Degradation study
The degradation studies in Hydrogen peroxide was carried out in accordance to section
UV Cabinet Degradation study
The specificity studies in UV cabinet was carried out in accordance to section 6.3.3. The sample when placed in UV cabinet for 24 hrs showed an average stability of 62.53% and hence the drug was found to degrade by 37.47% which is substantial.
Stability Chamber Degradation study
The degradation studies in Stability chamber was carried out in accordance to section 6.3.3 When study was carried out in stability chamber for 24 hrs, the data obtained was well within the accepted range with an average percent purity of 95.26% and hence only 4.74% was found to degrade in the aggravated stability conditions.
Oven Degradation study
The degradation studies in Stability chamber was carried out in accordance to section 6.3.3
Cleaning Method Validation Linearity
The linearity data was considered in accordance with the method development data for Metformin.
Range
The range for cleaning validation study was determined from the linearity data of method development. The range for the analytical data was found to be 0.1 µg/ml -25 µg/ml Placebo Plate Preparation The absorbance of the sample obtained by swabbing the placebo (water) plate was determined and found to be as 0.0013. From the absorbance obtained, it can be concluded that the interference due to water used as a cleaning solvent is nil and hence, it can effectively be used as a cleaning solvent without any interference in the results.
Metformin HCL Plate Preparation
The absorbance of the sample obtained by swabbing the Metformin Standard Plate was found to be 0.6764. The theoretical absorbance of the 10 ppm solution obtained from the calibration curve was 0.7676. Hence, there is negligible difference between the two concentrations obtained so the standard calibration curve can be used for the calculation purpose of cleaning validation method. Recovery 100 g Metformin HCl was taken for processing along with other excipients to perform granulation and compression.
Percent Recovery =Observed
A) For Swab Sampling Validation
To 10 ppm of Metformin drug solution 80%, 100% and 120% of the bulk drug powder was added respectively and processed in the similar manner as for the Metformin Swab Sampling.
The data was obtained as follows:
Limit of detection (LOD) and Limit of quantitation (LOQ) LOD and LOQ were considered same as that for the method validation of metformin.
For Powder Blender
The consecutive batches containing 100 g Metformin along with excipients was taken for blending. The blend was mixed for 20 minutes at 100 rpm. Further, the blend was collected and the blender was washed according to the cleaning procedure. The blender was swabbed at "difficult to clean"areas like shaft, internal joints and threads.
a) For Swab Sampling
The swabbing of the powder blender was performed after cleaning and the absorbance of the water in which, swab was dipped was determined.
Results and Discussion
Melting Point of the drug (Metformin) was found to be in the range of 217 
Linearity:
Forced degradation Studies NaOH degradation study
The degradation studies in 0.1 N NaOH was carried out in accordance to section 6.3.3 Table 3 .Degradation studies in NaOH.
Sr.
No.
Absorbance
Concentration in g/100ml
Percentage Purity From the above data it was concluded that Metformin HCl in forced condition of degradation with 0.1 N NaOH was found to be less stable and hence there was about average percent purity of 65.23% which implies a degradation of about 35% which is significant.
Hydrogen peroxide Degradation study
The degradation studies in Hydrogen peroxide was carried out in accordance to section 6.3.3 From the above data obtained from Hydrogen peroxide studies it can be made out that metformin in forced condition of degradation with hydrogen peroxide was found to be less stable and hence there was about average percent purity of 63.27% and hence there was degradation of 36.72%.
UV Cabinet Degradation study:
The specificity studies in UV cabinet was carried out in accordance to section 6.3.3 Table 5 . Degradation studies in UV Cabinet.
Sr.
Absorbance Concentration in g/100ml
Percentage Purity The sample when placed in UV cabinet for 24 hrs showed an average stability of 62.53% and hence the drug was found to degrade by 37.47% which is substantial.
Stability Chamber Degradation study:
The degradation studies in Stability chamber was carried out in accordance to section 6.3.3 Table 6 . Degradation study in stability chamber.
Sr.
Absorbance Concentration in g/100ml
Percentage Purity When study was carried out in stability chamber for 24 hrs, the data obtained was well within the accepted range with an average percent purity of 95.26% and hence only 4.74% was found to degrade in the aggravated stability conditions.
Oven Degradation study
The degradation studies in Stability chamber was carried out in accordance to section 6.3.3 The recovery data was found to be well within the limits with the recovery of 98.76%-99.5 %. And the RSD average value was found as 0.3712% which is much less than 2% and hence the method was accurate. Precision a) Intra-day Precision Table 9 .Intraday precision data. The intra-day precision was found to comply with the standards and also same was the fact with inter-day precision. The % RSD values in both the cases were below 2% and hence the method was found to be precise. For robustness study with change in analyst the drug was found to comply with the standards and also same was the fact with change in the equipments. The % RSD values in both the cases were below 2% and hence the method was found to be robust.
Robustness a) Change in Analyst
Limit of detection (LOD) and Limit of Quantitation (LOQ)
Drug LOD (µg/ml) LOQ (µg/ml) Metformin HCl 0.0226 0.0685 Table 13 .LOD and LOQ Data.
Cleaning Method Validation Linearity
Range
The range for cleaning validation study was determined from the linearity data of method development.
The range for the analytical data was found to be 0.1 µg/ml -25 µg/ml
Placebo Plate Preparation
The absorbance of the sample obtained by swabbing the placebo (water) plate was determined and found to be as 0.0013. From the absorbance obtained, it can be concluded that the interference due to water used as a cleaning solvent is nil and hence, it can effectively be used as a cleaning solvent without any interference in the results.
Metformin HCL Plate Preparation
The absorbance of the sample obtained by swabbing the Metformin Standard Plate was found to be 0.6764. The theoretical absorbance of the 10 ppm solution obtained from the calibration curve was 0.7676. Hence, there is negligible difference between the two concentrations obtained so the standard calibration curve can be used for the calculation purpose of cleaning validation method.
Percent Recovery =Observed ValueX 100
Theoretical Value = 0.6764 X 100 0.7676 = 88% Recovery 100 g Metformin HCl was taken for processing along with other excipients to perform granulation and compression.
A) For Swab Sampling Validation
To 10 ppm of Metformin drug solution 80%, 100% and 120% of the bulk drug powder was added respectively and processed in the similar manner as for the Metformin Swab Sampling. The data was obtained as follows: The intraday and inter-day precision of the cleaning method was determined by carrying out the analysis of the sample of 100% recovery study on three different times in a day and on three different days. The percent recovery and % RSD was found to be within specified limits and hence the method was precise.
Limit of detection (LOD) and Limit of quantitation (LOQ)
LOD and LOQ were considered same as that for the method validation of metformin.
For Powder Blender
The consecutive batches containing 100 g Metformin along with excipients was taken for blending. The blend was mixed for 20 minutes at 100 rpm. Further, the blend was collected and the blender was washed according to the cleaning procedure. The cleaning procedure comprised of: a) Cleaning with Hot Distilled Water (70 0 C). b) Cleaning with IPA 60 % solution (Disinfection). c) Cleaning with Distilled Water (RT) The blender was swabbed at "difficult to clean' areas like shaft, internal joints and threads.
a) For Swab Sampling
The swabbing of the powder blender was performed after cleaning and the absorbance of the water in which, swab was dipped was determined. 
b) For Rinse Sampling
The rinsing of the powder blender was performed after cleaning and the absorbance of the water was determined. The mg/ swab found for both swab and rinse sampling was found to be within the MACO limit for the instrument. Hence the cleaning procedure used was effective to remove all the remaining traces of drug from the equipment and hence can be used for routine cleaning purpose.
Sieves
The consecutive batches containing 100 g Metformin along with excipients was taken for sieving. The blend was sieved for 10 minutes. Further, the blend was collected and the sieve was washed according to the cleaning procedure mentioned in Section 6.5.5. a) Rinse Sampling Sieves were treated in the similar manner as that of powder blender and further analysis of rinsed samples was performed. The mg/ swab found for rinse sampling was found to be within the MACO limit for the instrument. Hence the cleaning procedure used was effective to remove all the remaining traces of drug from the equipment and hence can be used for routine cleaning purpose.
Compression Machine Hopper
The consecutive batches containing 100 g Metformin along with excipients were further taken for compression. The blends were then processed to prepare batch of 50 tablets. Further, the tablets were collected and the machine was cleaned according to the cleaning procedure mentioned in Section 6.4.5. a) Swab sampling Compression Machine Hopper was swabbed in the similar manner at "difficult to clean"areas as that of powder blender and further analysis were performed. The mg/ swab found for both swab and rinse sampling was found to be within the MACO limit for the instrument. Hence the cleaning procedure used was effective to remove all the remaining traces of drug from the equipment and hence can be used for routine cleaning purpose.
Compression Machine Turret
The consecutive batches containing 100 g Metformin along with excipients were further taken for compression. The blends were then processed to prepare batch of 50 tablets. Further, the tablets were collected and the machine was cleaned according to the cleaning procedure mentioned in Section 6.4.5. a) Swab sampling Compression Machine Turret was swabbed in the similar manner at "difficult to clean' areas as that of powder blender and further analysis were performed. The mg/ swab found for swab sampling was found to be within the MACO limit for the instrument. Hence the cleaning procedure used was effective to remove all the remaining traces of drug from the equipment and hence can be used for routine cleaning purpose.
Conclusion
A simple to use UV method to quantify residues of the active pharmaceutical ingredient Metformin Hydrochloride on swabs and in rinsed samples, in support of cleaning validation of pharmaceutical manufacturing equipment, was developed. Validation studies showed that the UV method is specific, linear, precise and accurate. To extract the Metformin Hydrochloride residue from the surface, a wipe test procedure using a nylon swab and rinsing is recommended. The recoveries obtained from the stainless steel surfaces were close to 88% or higher and there was no interference from the nylon swab. Stability studies show that the results of study are specific for the Metformin Hydrochloride drug. 
